FDA Grants Fast Track Designation to Efzofitimod for the Treatment of Pulmonary Sarcoidosis
ADC评论
August 13, 2022
On August 11, aTyr Pharma announced that the FDA has granted Fast Track designation to Efzofitimod (ATYR1923) for the treatment of pulmonary sarcoidosis. This year,
